All In MedTech

Device Trial Radar · NCT02686125

Vercise™ DBS Dystonia Prospective Study

Prospective Study of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Mar 7, 2016

Primary completion

Dec 2030

Study completion Dec 2030

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Feb 19, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 7 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.

Conditions

  • Dystonia

Interventions

  • Deep Brain Stimulation (DBS)Device

    Subjects receiving Deep Brain Stimulation (DBS) for the treatment of their dystonia symptoms will be offered participation in this registry.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects with reduction in dystonia symptoms as assessed by BFMDRS scoreTime frame: up to 3 years
  2. Proportion of cervical dystonia subjects with reduction in symptoms as assessed by TWSTRS scoreTime frame: up to 3 years

Locations

36 sites in 12 countries. Site status is shown where the registry gives one.

  • AZ Sint-Lucas

    Ghent, Belgium · Terminated

  • UZ Gasthuisberg

    Leuven, Belgium · Recruiting

  • Queen Elizabeth II Health Sciences Center

    Halifax, Canada · Recruiting

33 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.